Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.48 USD | -0.14% | +6.94% | +54.37% |
04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Chart calendar Alvotech
Upcoming events on Alvotech
Past events on Alvotech
2024-04-03 08:15 | Business Update Call |
2024-03-22 10:00 | Capital Markets Day |
2024-03-21 08:00 | Q4 2023 Earnings Call |
2024-03-20 16:15 | Q4 2023 Earnings Release |
2023-11-29 08:00 | Q3 2023 Earnings Call |
2023-11-28 16:15 | Q3 2023 Earnings Release |
2023-11-15 08:00 | Jefferies London Healthcare Conference |
2023-09-18 | Northland Capital Markets Institutional Investor Conference |
2023-08-31 08:00 | Q2 2023 Earnings Call |
2023-08-30 16:15 | Q2 2023 Earnings Release |
2023-06-07 16:30 | Jefferies Global Healthcare Conference |
2023-06-06 03:00 | Annual General Meeting |
2023-05-22 10:15 | Morgan Stanley Sustainable Finance Summit |
2023-05-19 08:00 | Q1 2023 Earnings Call |
2023-05-19 05:00 | Q1 2023 Earnings Release |
2023-03-02 08:00 | Q4 2022 Earnings Call |
2023-03-01 16:30 | Q4 2022 Earnings Release |
2022-11-17 05:25 | Jefferies London Healthcare Conference |
2022-11-16 08:00 | Q3 2022 Earnings Call |
2022-11-14 | Q3 2022 Earnings Release After hours |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 36,8 | 83,0 104 -20.49% | 93,4 133 -29.99% | 321 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -326 -212 -53.62% | -331 -271 -21.8% | 60,7 |
EBIT Million USD | Released Forecast Spread | 0,00 | -346 -260 -33.47% | -355 -254 -39.67% | -25,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -552 -375 -47.16% | -651 -346 -88.16% | -184 |
Net income Million USD | Released Forecast Spread | 0,00 | -514 -313 -64.08% | -552 -271 -103.47% | -149 |
EPS USD | Released Forecast Spread | -12,3 | -2,60 -1,55 -67.68% | -2,43 -1,09 -123% | -0,60 |
Announcement Date | 10/05/22 | 01/03/23 | 20/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q2 |
---|---|---|
Net income Million USD | Released Forecast Spread | 189 |
EPS USD | Released Forecast Spread | 0,85 |
Announcement Date | 30/08/23 |
Past sector events for Alvotech
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVO Stock
- ALVO Stock
- Calendar Alvotech